Evidence map›Paper›PMID 41618566›Full record

ArticleBiophysical journal2026

Protein structure and coupled solvent dynamics in α-synuclein fibrils under controlled confinement.

Katie Lynn Whitcomb, Kurt Warncke

Abstract read
In one paragraph

Article in Biophysical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Katie Lynn WhitcombDepartment of Physics, Emory University, Atlanta, Georgia 30322.
Kurt WarnckeDepartment of Physics, Emory University, Atlanta, Georgia 30322. Electronic address: kwarncke@physics.emory.edu.

Funding

Co(II) Radical Pair Dynamics in B12 Enzyme CatalysisR01GM142113 · NIGMS · EMORY UNIVERSITY · PI WARNCKE, KURT · 2020 to 2023
$1.3M
Electron Paramagnetic Resonance SpectrometerS10RR017767 · NCRR · EMORY UNIVERSITY · PI WARNCKE, KURT · 2003 to 2003
$261k
NCRR NIH HHS S10 RR017767NIGMS NIH HHS R01 GM142113
6 · The paper itself

Abstract

The formation of amyloid fibrils by the intrinsically disordered protein α-synuclein in human brain neurons and extracellular tissue is a hallmark of Parkinson disease. Although the stable protein β-structure in α-synuclein fibrils has been determined at high resolution, the status of the dynamically disordered domains and their responses to in vivo confinement and small-molecule interactions remain elusive. We use electron paramagnetic resonance spectroscopy of the spin probe, TEMPOL, colocalized with α-synuclein fibrils, and temperature-controlled, ice boundary confinement to characterize the physical and mechanical properties of the dynamically disordered protein and surrounding coupled solvent regions. The spin probe rotational correlation time at all temperature (T) values is characterized by two motional components, which are assigned to dynamically disordered protein terminal and hydration phases around the central fibril β-structure. The observed transformation from fast to slow motion components with decreasing T and increasing confinement is proposed to proceed through compaction 1 (protein collapse and folding) and compaction 2 (collapse and restriction) processes, intervened by tertiary structure consolidation and stable hydration layer formation. Hysteresis in the return, increasing T direction originates from frustration of cooperative dynamics of the spatially overlapping terminal domains and reveals bistability of compact, low-enthalpy and disordered high-entropy structures. Arrhenius and van't Hoff analyses support the proposed molecular model and indicate that compaction transitions are accessible under physiological conditions. Confinement relief effects of the small molecule dimethylsulfoxide are consistent with the model. The system and results provide a robust platform for assessment of α-synuclein fibril-targeted drugs.

Indexed as

alpha-SynucleinAmyloidSolventsHumansProtein Structure, SecondaryTemperaturealpha-SynucleinAmyloidSolvents

Identifiers

PMID41618566
PMCPMC13290376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.